-
EP0089062
European procedure
Extract from the Register of European Patents
EP About this file: EP0089062
| EP0089062 - Immunoprophylactic and immunotherapeutic agent [Right-click to bookmark this link] | |||
| Former [1983/38] | Immunoprophylactic and immunotherapeutic agents | ||
| [1990/49] | Status | No opposition filed within time limit Status updated on 10.10.1991 Database last updated on 13.07.2024 | Most recent event Tooltip | 10.10.1991 | No opposition filed within time limit | published on 27.11.1991 [1991/48] | Applicant(s) | For all designated states AJINOMOTO CO., INC. 5-8, Kyobashi 1-chome, Chuo-ku Tokyo 104 / JP | [1983/38] | Inventor(s) | 01 /
Yoshimoto, Ryota No. 958, Kashimada Saiwa-ku Kawasaki-shi Kanagawa-ken / JP | 02 /
Kashima, Nobukazu No. 2-21-603, Wakabada Asahi-ku Yokohama-shi Kanagawa-ken / JP | 03 /
Hamuro, Junji No. 241-32, Fukaya-cho Totsuka-ku Yokohama-shi Kanagawa-ken / JP | 04 /
Mitsugi, Koji No. 80-170, Nakazawa-cho Asahi-ku Yokohama-shi Kanagawa-ken / JP | [1983/38] | Representative(s) | Schübel-Hopf, Ursula, et al Strehl Schübel-Hopf Groening & Partner Patentanwälte Postfach 22 14 55 80504 München / DE | [N/P] |
| Former [1983/38] | Schübel-Hopf, Ursula, et al Strehl Schübel-Hopf Groening & Partner Patentanwälte Postfach 22 14 55 D-80504 München / DE | Application number, filing date | 83102562.2 | 15.03.1983 | [1983/38] | Priority number, date | JP19820040369 | 15.03.1982 Original published format: JP 4036982 | [1983/38] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | EP0089062 | Date: | 21.09.1983 | Language: | EN | [1983/38] | Type: | A3 Search report | No.: | EP0089062 | Date: | 05.02.1986 | Language: | EN | [1986/06] | Type: | B1 Patent specification | No.: | EP0089062 | Date: | 05.12.1990 | Language: | EN | [1990/49] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 02.12.1985 | Classification | IPC: | A61K37/02, A61K37/66, A61K39/39 | [1990/49] | CPC: |
C07K14/55 (EP,US);
A61K31/716 (EP,US);
A61K38/21 (EP,US);
A61P35/00 (EP);
A61K38/00 (EP,US)
| C-Set: |
A61K38/21, A61K2300/00 (US,EP);
A61K39/00, A61K38/00 (EP,US) |
| Former IPC [1983/38] | A61K37/02, A61K39/39, A61K45/02 | Designated contracting states | CH, DE, FR, GB, LI, SE [1983/38] | Title | German: | Immunoprophylaktisches und immunotherapeutisches Mittel | [1990/49] | English: | Immunoprophylactic and immunotherapeutic agent | [1990/49] | French: | Agent immunoprophylactique et immunothérapeutique | [1990/49] |
| Former [1983/38] | Immunoprophylaktische und immunotherapeutische Mittel | ||
| Former [1983/38] | Immunoprophylactic and immunotherapeutic agents | ||
| Former [1983/38] | Agents immunoprophylactiques et immunothérapeutiques | Examination procedure | 24.12.1984 | Examination requested [1985/11] | 02.05.1988 | Despatch of a communication from the examining division (Time limit: M06) | 14.11.1988 | Reply to a communication from the examining division | 13.07.1989 | Despatch of a communication from the examining division (Time limit: M02) | 25.09.1989 | Reply to a communication from the examining division | 18.12.1989 | Despatch of communication of intention to grant (Approval: No) | 21.05.1990 | Despatch of communication of intention to grant (Approval: later approval) | 31.05.1990 | Communication of intention to grant the patent | 04.09.1990 | Fee for grant paid | 04.09.1990 | Fee for publishing/printing paid | Opposition(s) | 06.09.1991 | No opposition filed within time limit [1991/48] | Fees paid | Renewal fee | 28.02.1985 | Renewal fee patent year 03 | 27.02.1986 | Renewal fee patent year 04 | 30.03.1987 | Renewal fee patent year 05 | 31.03.1988 | Renewal fee patent year 06 | 31.03.1989 | Renewal fee patent year 07 | 22.03.1990 | Renewal fee patent year 08 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XP]EP0049611 (HOOPER TRADING CO NV [NL]) | [X] - JOURNAL OF IMMUNOLOGY, vol. 126, no. 5, May 1981, pages 1680-1683, The Williams & Wilkins Co., US; D. STULL et al. : "Constitutive production of interleukin 2 activity by a T cell hybridoma" | [X] - JOURNAL OF IMMUNOLOGY, vol. 126, no. 6, June 1981, pages 2321-2327, The Williams & Wilkins Co., US; K. KURIBAYASHI et al.: "Murine NK cultures; effects of interleukin-2 and interferon on cell growth and cytotoxic reactivity" | [X] - NATURE, vol. 284, 20th March 1980, pages 278-280, Macmillan Journals ltd.; H. WAGNER et al.: "T-cell-derived helper factor allows in vivo induction of cytotoxic T cells in nu/nu mice" | [Y] - CHEMICAL ABSTRACTS, vol. 94, no. 25, 22th June 1981, page 455, no. 207041a, Columbus, Ohio, US; T. AOKI et al.: "Staphage lysate and lentinan as immunomodulators and/or immunopotentiators in clinical and experimental systems", & PROG. CANCER RES. THER. 1981, 16, 101-12 | [XP] - CHEMICAL ABSTRACTS, vol. 99, no. 11, 12th September 1983, page 433, no. 86443a, Columbus, Ohio, US; A.H. ROOK et al. : "Interleukin-2 enhances the depressed natural killer and cytomegalovirus-specific cytotoxic activities of lymphocytes from patients with the acquired immune deficiency syndrome", & J. CLIN. INVEST. 1983, 72(1), 398-403 |